TUCANAT 150MG TABLET

Form: Tablets

Pack Size: 60 TABLETS

Marketed by: NATCO PHARMA LTD (ONCOLOGY DIV)

MRP: ₹34778.55

NATCO PHARMA LTD (ONCOLOGY DIV): Tucanat 150MG Tablet, 60 tablets, salt tucatinib 150mg. NPPA has revised its MRP from Rs 42,187.50 to Rs 34,778.55 (18% lower) with effect from 09-11-2026; trade rate Rs 26,497.94. Group: HER2 tyrosine kinase inhibitor (targeted therapy). Same salt is also supplied by Hetero, MSN, Torrent. Handling/counselling: given with trastuzumab and capecitabine; check the full regimen. Schedule H - supply only to licensed buyers and dispense only on prescription.

Available at wholesale price for chemists, retailers and distributors on WholesaleChemist.